These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1973862)

  • 41. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells.
    Cho Y; Klein MG; Talmage DA
    Cell Growth Differ; 1998 Feb; 9(2):147-54. PubMed ID: 9486851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differentiated murine F9 teratocarcinoma cells are susceptible to apoptosis upon contact with substrate].
    Lianguzova MS; Pospelov VA; Kisliakova TV
    Tsitologiia; 2000; 42(10):955-63. PubMed ID: 11200135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuronal differentiation in F9 embryonal carcinoma cells.
    Wartiovaara J; Liesi P; Rechardt L
    Cell Differ; 1984 Dec; 15(2-4):125-8. PubMed ID: 6100170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The adenovirus Ela gene induces differentiation of F9 teratocarcinoma cells.
    Montano X; Lane DP
    Mol Cell Biol; 1987 May; 7(5):1782-90. PubMed ID: 2439896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells.
    Fujimura FK; Silbert PE; Eckhart W; Linney E
    J Virol; 1981 Jul; 39(1):306-12. PubMed ID: 6268818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
    Evain D; Binet E; Anderson WB
    J Cell Physiol; 1981 Dec; 109(3):453-9. PubMed ID: 6274880
    [No Abstract]   [Full Text] [Related]  

  • 48. Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid.
    Thompson S; Stern PL; Webb M; Walsh FS; Engstrom W; Evans EP; Shi WK; Hopkins B; Graham CF
    J Cell Sci; 1984 Dec; 72():37-64. PubMed ID: 6085330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.
    Oren M; Reich NC; Levine AJ
    Mol Cell Biol; 1982 Apr; 2(4):443-9. PubMed ID: 6287239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nerve growth factor induces adrenergic neuronal differentiation in F9 teratocarcinoma cells.
    Liesi P; Rechardt L; Wartiovaara J
    Nature; 1983 Nov 17-23; 306(5940):265-7. PubMed ID: 6139754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of cloned sequences complementary to F9 cell double-stranded RNA and their expression during differentiation.
    Schmitt HP; Kühn B; Alonso A
    Differentiation; 1986; 30(3):205-10. PubMed ID: 3754522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of F9 embryonal carcinoma cells. Differences in the effects of retinoic acid, 5-bromodeoxyuridine, and N'-N'-dimethylacetamide.
    Moore EE; Mitra NS; Moritz EA
    Differentiation; 1986; 31(3):183-90. PubMed ID: 3021554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmentally regulated surface structures of teratocarcinoma stem cells studied by mutant cell lines.
    Dráber P; Vojtísková M
    Cell Differ; 1984 Dec; 15(2-4):249-53. PubMed ID: 6535647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines.
    Parodi MT; Varesio L; Tonini GP
    Cancer Chemother Pharmacol; 1989; 25(2):114-6. PubMed ID: 2598398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid.
    Solter D; Shevinsky L; Knowles BB; Strickland S
    Dev Biol; 1979 Jun; 70(2):515-21. PubMed ID: 89977
    [No Abstract]   [Full Text] [Related]  

  • 56. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture.
    Andrews PW; Goodfellow PN; Shevinsky LH; Bronson DL; Knowles BB
    Int J Cancer; 1982 May; 29(5):523-31. PubMed ID: 7095898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rescue of terminally differentiating teratocarcinoma cells by fusion to undifferentiated parental cells.
    Littlefield JW; Felix JS
    Somatic Cell Genet; 1982 Nov; 8(6):743-57. PubMed ID: 6891836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell surface glycoproteins as markers in monitoring in vitro differentiation of embryonal carcinoma cells.
    Muramatsu T
    Cell Differ; 1984 Dec; 15(2-4):101-8. PubMed ID: 6152579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spontaneous differentiation in the colonies of a nullipotent embryonal carcinoma cell line (F9).
    Zákány J; Burg K; Raskó I
    Differentiation; 1984; 27(2):146-51. PubMed ID: 6479493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in various differentiation-related markers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide].
    Kimura H; Sekiya S; Kawata M; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Nov; 43(11):1477-83. PubMed ID: 1682397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.